Skip to main content
Figure 1 | BMC Microbiology

Figure 1

From: In vitro synergism of fosfomycin and clarithromycin antimicrobials against methicillin-resistant Staphylococcus pseudintermedius

Figure 1

Enhanced antibacterial activity of fosfomycin (FOS) and clarithromycin (CLA) against MRSP following 24 h growth. Biofilm forming potential of one ST68 strain (A12) and seven ST71 strains (A46, A56, A92, SP90, SP106, SP112, SP113) and the effect of FOS and CLA in mono and combination therapy. Combination therapy had a significant effect (P < 0.05) while low doses of FOS and CLA alone had no significant effect (P > 0.05) on MRSP biofilm formation.

Back to article page

BMC Microbiology

ISSN: 1471-2180

Contact us